Results

Total Results: 1,430 records

Showing results for "continue".

121. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
     January 01, 2007 - symptoms or conditions associated with cough), and health outcomes, particularly for individuals who continue

122. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1506.pdf
     December 01, 2015 - We continue to survey available outlets for information on novel interventions and new applications

123. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_executive.pdf
     May 01, 2010 - Recognizing that observational studies will continue to be attractive to investigators, the usefulness

124. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - We continue to survey multiple channels for innovative interventions and new uses of existing therapies

125. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Although recent progress has been limited, researchers continue to investigate genetic and neurobiological

126. Comparing Talk Therapy and Other Depression Treatments With Antidepressant Medicines (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_consumer.pdf
     September 01, 2016 - � If a treatment helps, how long would I need to continue it?

127. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0352_09-22-2010.pdf
     January 01, 2010 - Effective Health Care Topic Number: 0298 Document Completion Date: 03-19-12 1 Results of Topic Selection Process & Next Steps  Perinatal depression treatment will go forward for refinement as a systematic review. The scope of this topic, including populations, interventions, comparators, and ou…

128. Insulin-Blood-Sugar-2010 Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
     January 01, 2010 - 1 Comparative Effectiveness Review Number 57 Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness Executive Summary Background Diabetes mellitus is defined as a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion from the pancreati…

129. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
     October 01, 2006 - Layout 1 Background Renal artery stenosis (RAS) is defined as the narrowing of the lumen of the renal artery. Atherosclerosis accounts for 90 percent of cases of RAS. Atherosclerotic RAS (ARAS) is a progressive disease that may occur alone or in combination with hypertension and ischemic kidney disease. The prevalenc…

130. Cesarean-Birth-2010 Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cesarean-birth-2010_executive.pdf
     January 01, 2010 - “There are no data that higher rates improve any outcomes, yet the CS [cesarean section] rates continue … This is a concern, as cesarean rates among low-risk women continue to rise, and the individual and

131. Clinical-Care-Rapid-Review-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/clinical-care-rapid-review-appendix-c.xlsx
     January 01, 2018 - List of Evidence Tables Category Evidence Table Characteristics Evidence Table C-1. Study characteristics of included primary studies Evidence Table C-2. Intervention characteristics of included primary studies Evidence Table C-3. Population characteristics of included primary studies Event reporting Evidence Ta…

132. Executive Summary_Systematic Review_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidence Base (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-executive-summ.pdf
     January 01, 2022 - Executive Summary_Systematic Review_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidence Base Systematic Review Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidenc…

133. Quality-Gap-Palliative-Hospice Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_executive.pdf
     October 01, 2012 - Evidence-Based Practice Evidence-based Practice Program The Agency for Healthcare Research and Quality (AHRQ), through its Evidence- based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to imp…

134. Executive Summary: Breastfeeding and Health Outcomes for Infants and Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-research-executive-summ.pdf
     March 01, 2025 - Executive Summary: Breastfeeding and Health Outcomes for Infants and Children Systematic Review Breastfeeding and Health Outcomes for Infants and Children Executive Summary Main Points Background and Purpose While it is widely accepted that breastfeeding and the consumption of human milk is…

135. Migraine Protocol-Appendix 20111103 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
     November 03, 2011 - Source: www.effectivehealthcare.ahrq.gov Published Online: November 3, 2011 A-1 Appendix A. Table A1. Pharmacological classes for migraine prevention Drug, ATC Code* Class of Drug ANTIEPILEPTICS Topiramate, N03AX11 N03 ANTIEPILEPTICS N03AX Other antiepileptics Lamotrigine, N03AX09 N03A ANTIEPI…

136. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
     October 01, 2011 - The role of selective, partially selective, and nonselective oral NSAIDs and alternative agents will continue

137. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
     February 01, 2012 - Recognizing that observational studies, including case series, and case reports will continue to be … Recognizing that observational studies, including case series, and case reports will continue to be … number of practices willing to be randomized can be a constraint, so sample size considerations may continue

138. Treatment Resistant Depression Surveillance FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
     April 01, 2016 - Treatment Resistant Depression Surveillance FINAL AHRQ Systematic Review Surveillance Program CER #33: …

139. Topic-Brief3-Sud (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
     April 01, 2021 - Patients maintained on buprenorphine for opioid use disorder should continue buprenorphine through … surgery) may reduce analgesic requirements and that pain may be effectively treated in patients who continue

140. Topic-Brief3-Sud (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief3-SUD.pdf
     April 01, 2021 - Patients maintained on buprenorphine for opioid use disorder should continue buprenorphine through … surgery) may reduce analgesic requirements and that pain may be effectively treated in patients who continue